|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 5, 2010
|
|
DELCATH SYSTEMS, INC.
|
||
|
(Exact Name of Registrant as Specified in Charter)
|
|
DELAWARE
|
001-16133
|
06-1245881
|
||||
|
(State of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
810 SEVENTH AVE, SUITE 3505
NEW YORK, NEW YORK
|
10019
|
|||
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
600 FIFTH AVENUE, 23RD FLOOR
NEW YORK, NEW YORK
|
||
|
(Former name or former address, if changed since last report.)
|
|
Registrant’s telephone number, including area code: (212) 489-2100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 8.01 Other Events.
On June 5, 2010, Delcath Systems, Inc. (“the Company”) highlighted the Phase III trial data presented on June 5 at the American Society of Clinical Oncology’s 2010 Annual Meeting. A copy of the Company’s June 5, 2010 press release is included in Exhibit 99.1 to this Current Report on Form 8-K.
|
|
Item 9.01 Financial Statements and Exhibits.
|
|
|
(d) Exhibits.
|
The following exhibits are filed with this report on Form 8-K:
|
|
Exhibit Number
99.1
|
Description of Exhibit
Press Release of Delcath Systems, Inc. dated June 5, 2010
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 7, 2010
|
|
DELCATH SYSTEMS, INC.
By: /s/ David A. McDonald
|
||
|
Name: David A. McDonald
Title: Chief Financial Officer
|